STOCK TITAN

Enlivex (ENLV) shareholders approve and complete corporate name change

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Enlivex Therapeutics Ltd. has formally changed its corporate name to Enlivex Ltd. following shareholder approval at an Extraordinary General Meeting held on February 3, 2026. Shareholders authorized the new name or another name containing the word “Enlivex,” subject to approval by the Israeli Registrar of Companies.

On February 10, 2026, the Registrar of Companies in Israel issued a Certificate of Change of Name, confirming the change to Enlivex Ltd. This certificate is attached as Exhibit 99.1 and the updated name is now incorporated by reference into the company’s existing U.S. registration statements on Forms S-8 and F-3.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of: February 2026

 

Commission file number: 001-36578

 

ENLIVEX LTD.

(Translation of registrant’s name into English)

 

14 Einstein Street, Nes Ziona, Israel 7403618

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

 

 

 

 

 

Change of Company’s Name

 

On February 3, 2026, Enlivex Therapeutics Ltd., a company organized under the laws of the State of Israel (the “Company”), held an Extraordinary General Meeting of Shareholders of the Company (the “Meeting”). At the Meeting, the shareholders voted on and approved (among other things) a proposal to change the Company’s name to “Enlivex Ltd.” or to such other name containing the word “Enlivex” as may be determined by the Company’s management and approved by the Israeli Registrar of Companies. On February 10, 2026, the Registrar of Companies in Israel issued a Certificate of Change of Name effecting the Company’s name change to Enlivex Ltd. (the “Certificate”). A complete copy of the Certificate is filed as Exhibit 99.1 to this Report on Form 6-K and incorporated herein by reference.

 

The information contained in this Report on Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the Company’s registration statements on Forms S-8, F-3 and F-3MEF (File No. 333-256799, File No. 333-232413, File No. 333-232009, File No. 333-252926, File No. 333-286956 and File No. 333-292417), filed with the U.S. Securities and Exchange Commission.

 

Exhibit No.  
   
99.1 Certificate of Change of Name, filed with the Registrar of Companies in Israel on February 10, 2026.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Enlivex Ltd.
  (Registrant)
   
  By: /s/ Oren Hershkovitz
 

Name: 

Title:

Oren Hershkovitz
Chief Executive Officer

 

Date: February 23, 2026

 

2

 

Exhibit 99.1

CERTIFICATE OF CHANGE OF NAME This is to certify that the company: Company Number: 514716489 Changed its name in Israel according to Companies Laws in the State of Israel, and beginning of 10TH FEBRUARY 2026 it will be called: Shuli Avni-Shoham, Adv. Registrar of Companies Head of the Israeli Corporations Authority PRODUCED ON 10TH FEBRUARY 2026 AT 17:00 To obtain a company information summary, scan the barcode or click here Produced on 10 th February 2026 At 17:00 ୭ " ୬ஂ஁୼ ஁୩୰ ୪ " ୳ 10 / 02 / 2026 ୩ୱ୭୵ ୬୭୼୿୬ 17:00 ୩஁୺୬ To obtain a company information summary, scan the barcode or click here , ஂ୶୾ୱஂ ୶ୱ୫୺ ୺୴ ୬୯୩஀୬ - ୴୬୼୿ஂ ୸୹୯ ୯୩஀୬ ୱ஁ ୴୹஀୭୿ ୨ஂ ୬୩஀୿୭୫ ୨୭ ୴୴୯୭୽ ୳୨୷ ஁୵ ஁ୱ୸୭ୱ ஂ୺୭୫ஂ CERTIFICATE OF CHANGE OF NAME : ୬୯୩஀୬ ୳ୱ ୴ஂ୺୭୫୬ ୭୮୨ஂ This is to certify that the company: ୶ " ୩୺ ஂ஀୼ୱ୭୰ୱ୿୹ ୨୸୴ୱୱ୩୿୹ ENLIVEX THERAPEUTICS LTD Company Number: 514716489 : ୯୩஀୬ ୶୹୼஀ Changed its name in Israel according to Companies Laws in the State of Israel, and beginning of 10 th February 2026 it will be called: ୩ୱ஁஀୨୴ ஁୶୬ ୨ஂ ஁ୱ୸ஂ୬ , ୱ஁஀୨୴ ୩୶୫ୱ୸ஂ ୬୯୩஀୭ஂ ୫ୱ୸ୱ ୴୼ୱ ୭ " ୬ஂ஁୼ ஁୩୰ ୪ " ୳ , 10 / 02 / 2026 ୶ୱ୭୵ ୭୬୯୴ : ୩஁୵ ஂୱ୿஀୨ ୶ " ୩୺ ୨୸୴ୱୱ୩୿୹ ENLIVEX LTD Shuli Avni - Shoham, Adv. Registrar of Companies Head of the Israeli Corporations Authority ୫ " ୺୭ , ஁୭୬୵ - ୨୩୸ୱ ஁୭୴ୱ ୬୯୩஀୭ஂ ஀஁୶ஂ ୬ஂ୨୪ୱ୫ୱ୵ ஀஁୭ஂ ஀୨஁

FAQ

What corporate change did Enlivex (ENLV) report in its latest Form 6-K?

Enlivex reported that it changed its corporate name from Enlivex Therapeutics Ltd. to Enlivex Ltd.. The name change followed shareholder approval at an Extraordinary General Meeting and was finalized when the Israeli Registrar of Companies issued a Certificate of Change of Name on February 10, 2026.

When did shareholders of Enlivex (ENLV) approve the company’s name change?

Shareholders approved the name change at an Extraordinary General Meeting held on February 3, 2026. At this meeting, they authorized changing the name to “Enlivex Ltd.” or another name containing “Enlivex,” subject to approval by the Israeli Registrar of Companies under Israeli company law requirements.

When did Enlivex Ltd. receive official confirmation of its new name in Israel?

Enlivex received official confirmation of its new name on February 10, 2026. On that date, the Israeli Registrar of Companies issued a Certificate of Change of Name stating that the company, registered as number 514716489, would be known as Enlivex Ltd. starting that same day.

How does Enlivex’s (ENLV) name change affect its U.S. registration statements?

The Form 6-K states that the information about the name change, including Exhibit 99.1, is incorporated by reference into Enlivex’s existing U.S. registration statements on Forms S-8 and F-3. This ensures those registrations reflect the updated corporate name Enlivex Ltd. without separate amendments.

What document evidences the Enlivex (ENLV) name change in the Form 6-K filing?

The name change is evidenced by Exhibit 99.1, titled “Certificate of Change of Name.” This certificate, issued by the Israeli Registrar of Companies, confirms that Enlivex Therapeutics Ltd. changed its name to Enlivex Ltd. effective February 10, 2026, under Israeli Companies Laws.

Filing Exhibits & Attachments

2 documents
Enlivex Therapeutics Ltd

NASDAQ:ENLV

ENLV Rankings

ENLV Latest News

ENLV Latest SEC Filings

ENLV Stock Data

239.76M
236.28M
Biotechnology
Healthcare
Link
Israel
Ness Ziona